HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.

All News Hainan Huluwa Pharmaceutical Group Co., Ltd.

Equities

605199

CNE100004223

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
10.33 ^CNY	+1.97%		-7.27%	-31.86%

05-01	Huluwa Pharmaceutical Gets Nod to Register Two Drugs	MT
04-26	Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Huluwa Pharmaceutical Gets Nod to Register Two Drugs	05-01	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Huluwa Pharma Gets Nod to Market Terbutaline Sulfate Inhaler	04-24	MT
Huluwa Pharma Gets Nod to Register Cefdinir Granules	02-20	MT
Huluwa Pharma Registers Ibuprofen Suspension	01-17	MT
Huluwa Pharma Registers Hypertension Drug	11-28	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Huluwa Pharmaceutical Gets Nod to Trial Epilepsy Drug	22/09/23	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd.(XSSC:605199) added to S&P Global BMI Index	18/09/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Hainan Huluwa Pharmaceutical Unit Gets Registration Certificate for Allergy Drug in China	04/08/23	MT
Huluwa Pharma's Supplementary Drug Application for Infection Treatment Wins Approval in China	06/06/23	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. completed the acquisition of 51% stake in Jiangxi Rongxing Pharmaceutical Co., Ltd. from Chen Xuerong.	19/04/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/04/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd. entered into an agreement to acquire 51% stake in Jiangxi Rongxing Pharmaceutical Co., Ltd. from Chen Xuerong for CNY 44.88 million	16/03/23	CI
Hainan Huluwa Pharmaceutical Group Co., Ltd.(XSSC:605199) dropped from S&P Global BMI Index	19/12/22	CI
Huluwa Pharmaceutical Gets Regulatory Approval For Drug Production Line in China's Hainan Province	18/11/22	MT
Hainan Huluwa Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Hainan Huluwa Pharmaceutical Unit Acquires Marketing License of 50 Drugs; Shares Up 3%	27/10/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Hainan Huluwa Pharmaceutical Group Co., Ltd.

Equities

605199

CNE100004223

All News

Filters